1 / 9

Authors: Rene Soria-Saucedo 1 , Veronika J. Wirtz 1 , Warren A. Kaplan 2

The volume share of generic medicines in the retail market between 1999 and 2009: a comparison between Brazil and Mexico . Authors: Rene Soria-Saucedo 1 , Veronika J. Wirtz 1 , Warren A. Kaplan 2

aglaia
Download Presentation

Authors: Rene Soria-Saucedo 1 , Veronika J. Wirtz 1 , Warren A. Kaplan 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The volume share of generic medicines in the retail market between 1999 and 2009: a comparison between Brazil and Mexico Authors: Rene Soria-Saucedo1, Veronika J. Wirtz1, Warren A. Kaplan2 Institutions: 1Center for Health Systems Research, National Institute of Public Health, Mexico; 2Center for Global Health and Development, Boston University, USA

  2. Study Objective • Analyze the relationship between the volume share of generic medicines in Mexico and Brazil between 1999 and 2009 and public policies to promote their use

  3. Study Design • Setting: Brazil and Mexico retail market • Methodology: • Time Series Analysis of the retail pharmaceutical market volume between 1999-2009 (IMS Health data). • Public policies’ assessment regarding promotion of generic medicines (literature review).

  4. Data analysis • Total annual sales volume in standard units • Stratification by: • Originator and licensed brand • Branded generic • Unbranded generic • Only retail data (sales volume) • Brazil: around 85% of total volume corresponds to retail • Mexico: about 50% of total volume corresponds to retail

  5. Data analysis • Literature review to identify policies implemented to promote generic medicines uptake • Agencies and organizations in charge of policy implementation • Mechanisms used to increase generic uptake (price regulations, labeling, public campaigns, etc) • Role of the national pharmaceutical industry • Differences between the policies implemented in the public and the private sector

  6. Results: Brazil Retail Sector Source: IMS Health

  7. Results: Mexico Retail Sector Source: IMS Health

  8. Potential reasons why generic market share increased faster in Brazil than in Mexico

  9. Study Conclusions • Even though both countries had similar political objectives to promote generic medicines, the strategies differed largely. • Brazilian pharmaceutical policies highly placed in the political agenda, ensured the technical, logistical and financial preconditions for medium and long term implementation of the policy and key stakeholders from the private sector supported the initiative. • Mexico targeted more effectively generic utilization in the public sector but was not successful in the retail market.

More Related